IP Verse

London Ec2v 7bq patent opposition analysis

The comprehensive analysis of London Ec2v 7bq opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by London Ec2v 7bq

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 22, 2025	DEVA HOLDING ANONIM SIRKETI
EP3973987	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Oct 10, 2024	MICHALSKI HTTERAMNN & PARTNER

Top companies who are the clients of London Ec2v 7bq

Company	Total
DEVA HOLDING ANONIM SIRKETI	1
MICHALSKI HTTERAMNN & PARTNER	1